These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9300733)

  • 1. Fractionation and glottic carcinoma.
    Fowler JF
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):1-2. PubMed ID: 9300733
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relation between overall treatment time and local control of early glottic laryngeal cancer: comparison of six versus five times per week].
    Kitano M; Nishiguchi I; Aoki Y; Nakayama M; Nagai H; Takahashi H; Okamoto M; Matsubayashi T; Hayakawa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Jun; 62(7):366-9. PubMed ID: 12136637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of radiotherapy for T1 carcinoma of the glottis by fractions of 2.3 Gy per day.
    Plataniotis GA; Kouvaris JR; Hatzimichalis HJ; Papavasiliou CG; Vlachos L
    Acta Oncol; 1997; 36(3):342-3. PubMed ID: 9208909
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of glottic carcinoma by megavoltage radiation therapy and results.
    Wang CC
    Am J Roentgenol Radium Ther Nucl Med; 1974 Jan; 120(1):157-63. PubMed ID: 4204019
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of T1N0 glottis carcinoma with radiotherapy. Results at our center and review of the literature].
    León X; Quer M; Orús C; de Vega M; Vergés J; Gañán L
    Acta Otorrinolaringol Esp; 2003 Jan; 54(1):39-47. PubMed ID: 12733319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [T1a glottic neoplasms: experience with surgery and radiotherapy].
    Nicolai P; Bovarini M; Bonfioli F; Bonetti B; Moretti R; Magno L; Antonelli AR
    Acta Otorhinolaryngol Ital; 1988; 8(6):581-90. PubMed ID: 3247844
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dose-time-volume factors in radiotherapy of T2N0M0 glottic cancer].
    Kagami Y; Nishiyama K; Ikeda H; Masaki N; Shigematsu Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Oct; 43(10):1194-8. PubMed ID: 6672748
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy for carcinoma of the supraglottis.
    Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ
    Otolaryngol Clin North Am; 1997 Feb; 30(1):145-61. PubMed ID: 8995142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high-risk group in early glottic carcinoma.
    Hordijk GJ
    Arch Otolaryngol; 1980 Oct; 106(10):621-2. PubMed ID: 7417091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of radiation therapy in stage I and II glottic squamous cell carcinoma.
    Witt RL
    Del Med J; 1995 Aug; 67(8):430-5. PubMed ID: 7664954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.
    Fein DA; Mendenhall WM; Parsons JT; Million RR
    Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):605-11. PubMed ID: 8454477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.
    Schrijvers ML; van Riel EL; Langendijk JA; Dikkers FG; Schuuring E; van der Wal JE; van der Laan BF
    Head Neck; 2009 Jun; 31(6):759-64. PubMed ID: 19260127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local control of T3N0 glottic carcinoma by 60 Gy given over five weeks in 2.4 Gy daily fractions. One more point on the biological effective dose (BED) curve.
    Jackson SM; Hay JH; Flores AD
    Radiother Oncol; 2001 May; 59(2):219-20. PubMed ID: 11325452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiation therapy in glottic laryngeal carcinoma stage. I. Results and analysis of prognostic factors].
    Skołyszewski J; Reinfuss M; Kowalska T; Walasek T; Dymek P
    Otolaryngol Pol; 1996; 50(3):243-7. PubMed ID: 9045160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of pre-operative radiotherapy for supraglottic larynx cancer.
    Hendrickson FR; Liebner E
    Ann Otol Rhinol Laryngol; 1968 Apr; 77(2):222-9. PubMed ID: 4967479
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
    Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
    Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of fractionation for patients with T2N0M0 glottic larynx cancer undergoing definitive radiotherapy in the United States.
    Stokes WA; Stumpf PK; Jones BL; Blatchford PJ; Karam SD; Lanning RM; Raben D
    Oral Oncol; 2017 Sep; 72():110-116. PubMed ID: 28797446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early glottic carcinoma: patterns and predictors of relapse after definitive radiotherapy.
    Kersh CR; Kelly MD; Hahn SS; Spaulding CA; Cantrell RW; Constable WC
    South Med J; 1990 Apr; 83(4):374-8. PubMed ID: 2321065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.